Understanding end-of-life in dementia patients using digital tools
Decoding Death and Dying in People With Dementia by Digital Thanotyping
This study is trying to use digital tools to better understand the dying process in people with dementia, so caregivers can provide better support during this difficult time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 480 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | University of Bergen Academic / other |
| Locations | 1 site (Bergen, Vestland) |
| Trial ID | NCT06437132 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop methods for accurately diagnosing and describing the dying process in individuals with dementia. By combining clinical assessments with wearable sensing technology, the study will monitor pain, distressing symptoms, and behavioral changes in nursing home residents. The goal is to identify the 'point of no return' in the dying process, providing a clearer understanding of end-of-life trajectories for this vulnerable population. The findings could also be applicable to other life-threatening conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are nursing home residents aged over 64 with a diagnosis of dementia who are not experiencing delirium.
Not a fit: Patients who are not diagnosed with dementia or are in a health status emergency may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of end-of-life care for dementia patients by providing healthcare professionals with better tools for symptom management and decision-making.
How similar studies have performed: While the approach of digital thanotyping is novel, similar studies have shown promise in improving end-of-life care in other patient populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Nursing home resident * \>64 years old * People with dementia or who have a likely diagnosis of dementia * Score of \<4 on the 4 A's Test for Delirium (4AT) will be required for inclusion (no delirium) Exclusion Criteria: * People without dementia or cognitive impairment * People that are considered already in a health status emergency (\< 6 weeks to live) * People that are not living in the nursing home * People without informed/presumed consent
Where this trial is running
Bergen, Vestland
- Bergen Røde Kors Sykehjem AS — Bergen, Vestland, Norway (Recruiting)
Study contacts
- Study coordinator: Bettina S. Husebø, PhD
- Email: bettina.husebo@uib.no
- Phone: 48094660
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.